• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7212
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Codes No Consequences Or Impact To Patient (2199); No Patient Involvement (2645)
Date of Event 08/28/2019
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that device sterility was compromised.During preparation of a 3.50mm x 12mm nc emerge balloon catheter, it was noticed that there was a handwritten note on the back of the internal sterilized packaging.The device was not used and the procedure was completed with another of the same device.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an nc emerge balloon catheter.The product packaging was visually examined.The pouch had been opened and a device and compliance chart were inside.The compliance chart had writing on the back.No other issues or damage were found on the pouch, carton, or device.The complaint investigation conclusion code is manufacturing deficiency as problems traced to manufacturing process.Further internal investigation is being completed to address this issue.
 
Event or Problem Description
It was reported that device sterility was compromised.During preparation of a 3.50mm x 12mm nc emerge balloon catheter, it was noticed that there was a handwritten note on the back of the internal sterilized packaging.The device was not used and the procedure was completed with another of the same device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9111484
Report Number2134265-2019-10863
Device Sequence Number2862627
Product Code LOX
UDI-Device Identifier08714729846413
UDI-Public08714729846413
Combination Product (Y/N)N
Initial Reporter StateAR
Initial Reporter CountryUS
PMA/510(K) Number
K141236
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/12/2021
Device Model Number7212
Device Catalogue Number7212
Device Lot Number0023946193
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/06/2019
Initial Date Received by Manufacturer 08/28/2019
Supplement Date Received by Manufacturer10/03/2019
Initial Report FDA Received Date09/24/2019
Supplement Report FDA Received Date10/22/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-